Latest Breaking News On - News ratings for paratek pharmaceuticals daily - Page 9 : vimarsana.com

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) – Equities researchers at HC Wainwright lowered their Q1 2023 earnings estimates for Paratek Pharmaceuticals in a report issued on Monday, March 20th. HC Wainwright analyst E. Arce now forecasts that the specialty pharmaceutical company will post earnings per share of ($0.27) for the quarter, down from their […]

Prospera financial services incCi private wealthArete wealth advisorsParatek pharmaceuticals company profileHedge funds weigh in on paratek pharmaceuticalsParatek pharmaceuticalsParatek pharmaceuticals incNews ratings for paratek pharmaceuticals dailyParatek pharmaceuticals stock performanceGet ratingParatek pharmaceuticalFinancial services incStreet groupWealth advisorsExoduspoint capital managementParatek pharmaceuticals daily